DMRA vs INVA: stock comparison and AI forecast
Damora Therapeutics, Inc. (DMRA) and Innoviva, Inc. (INVA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DMRA Damora Therapeutics, Inc.
- Market Cap
- $1.35B
- P/E Ratio
- 2.1x
- Size
- small-cap
- AI Forecast
INVA Innoviva, Inc.
- Market Cap
- $1.39B
- P/E Ratio
- 8.5x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DMRA and INVA have similar market capitalizations ($1.35B and $1.39B).
- DMRA trades at 2.1 times trailing earnings, INVA at 8.5 times.
- INVA carries 0.35 times debt per unit of equity, against 0.07 times for DMRA.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DMRA | INVA |
|---|---|---|
| Market Cap | $1.35B | $1.39B |
| P/E Ratio | 2.09x | 8.48x |
| P/B Ratio | 2.72x | 1.22x |
| EPS | $10.46 | $2.27 |
| Book Value/Share | $8.03 | $15.75 |
| Revenue/Share | – | $0.42 |
| FCF/Share | – | $2.53 |
Profitability & Margins
| Metric | DMRA | INVA |
|---|---|---|
| ROE | – | 17.0% |
| ROA | – | 12.6% |
| ROIC | -61.3% | 11.4% |
| Operating Margin | – | 566.2% |
| Net Margin | – | 643.7% |
| EBT Margin | – | 745.2% |
| Tax Rate | -0.1% | 13.6% |
Financial Health
| Metric | DMRA | INVA |
|---|---|---|
| Current Ratio | 14.80x | 15.44x |
| Quick Ratio | – | 14.58x |
| D/E Ratio | 0.07x | 0.35x |
| Financial Leverage | 1.07x | 1.35x |
| Interest Coverage | -8.9x | 7.7x |
| Working Capital | $495M | $722M |
Cash Flow
| Metric | DMRA | INVA |
|---|---|---|
| Operating Cash Flow | -$59M | $183M |
| Free Cash Flow | – | $183M |
| Capital Spending | – | -$950K |
| OCF Growth YoY | – | -9.0% |
| FCF/Sales | – | 607.3% |
| CapEx/Sales | – | 3.2% |
Operational Efficiency
| Metric | DMRA | INVA |
|---|---|---|
| Asset Turnover | – | 0.02x |
| Receivables Turnover | – | 0.7x |
| Fixed Assets Turnover | – | 14.8x |
| Days Sales Outstanding | – | 535 days |
Income Statement
| Metric | DMRA | INVA |
|---|---|---|
| Total Revenue | – | $30M |
| Operating Income | -$304M | $170M |
| Net Income | – | $193M |
| R&D Expense | $98M | $20M |
| SG&A Expense | – | $136M |
Dividend & Shareholder Information
| Metric | DMRA | INVA |
|---|---|---|
| Shares Outstanding | 62M | 72M |
| Net Income Growth | – | 51.9% |
| EPS Growth | – | 59.9% |
DMRA vs INVA: stock comparison and AI forecast
Which is bigger, DMRA or INVA?
DMRA and INVA have similar market capitalizations ($1.35B and $1.39B).
Which is cheaper on earnings, DMRA or INVA?
DMRA trades at 2.1 times trailing earnings, INVA at 8.5 times.
Which one does Intratio's AI model rank higher, DMRA or INVA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.